Last checked at 2 Apr 2009 15:27
| ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES") |
| COMPANY NAME: |
| Evolutec Group plc |
| COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES) : |
| 3 More London Riverside, London, SE1 2AQ |
| COUNTRY OF INCORPORATION: |
| England & Wales |
| COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26: |
| www.evolutec.com |
| COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING STRATEGY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED: |
| Evolutec Group plc ("Evolutec") is classed as an investment company under the AIM Rules. The investment policy of Evolutec has been to seek a single investment, most probably of a UK or European business, in either the technology, healthcare or service related sectors. The main country of operation is England. The boards of Evolutec and Nanoco Tech Public Limited Company ("Nanoco") have reached agreement on the terms of recommended share acquisition by Evolutec of the entire issued and to be issued share capital of Nanoco to be effected by means of a court approved scheme of arrangement. Admission is sought as a result of a reverse take-over under Rule 14. Nanoco is a leading nanotechnology company involved in the development and manufacture of fluorescent semi-conducting materials called quantum dots. Quantum dots are a platform technology with uses in a wide range of applications from life sciences through to optoeletronics dominated by solid state lighting, photovoltaics and next generation displays. Quantum dot based applications have the ability to potentially offer significant benefits in performance and energy savings compared to those materials currently used. |
| DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares): |
| 184,088,032 Ordinary Shares of 10p each |
| CAPITAL TO BE RAISED ON ADMISSION (IF APPLICABLE) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION: |
| Anticipated market capitalisation upon admission - £45,561,787 |
| PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION: |
| 83.56% |
| DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM SECURITIES (OR OTHER SECURITIES OF THE COMPANY) ARE OR WILL BE ADMITTED OR TRADED: |
| N/A |
| FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is known or including any other name by which each is known): |
| Directors Dr. David Philip Bloxham - Non-Executive Chairman Gordon James Hall - Non-Executive Director Mark Barrie Hawtin - Non-Executive Director Graeme Manson Hart - Non-Executive Director Proposed Directors Dr. Peter John Rowley - Non-Executive Chairman Dr. Michael Albert Edelman - Chief Executive Officer Dr. Nigel Leroy Pickett - Chief Technical Officer Michael Anthony Bretherton - Chief Financial Officer Upon Admission the board of the Company will comprise of the Proposed Directors and Gordon James Hall. |
| FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known): |
| Before Admission Gartmore Investment Management Limited - 25.99% Kisco Limited - 12.16% Fortis Bank - 11.06% GAM International - 10.87% Close Asset Management - 5.07% Charles Stanley - 4.24% After Admission ORA Guernsey - 36.34% Gartmore - 16.10% Mitsubishi UFJ - 6.45% Nigel Pickett - 5.67% Paul O'Brien - 5.39% Michael Edelman - 5.03% Manchester Tech Fund - 3.73% Nora Powell - 3.26% |
| NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES: |
| None |
| ANTICIPATED ACCOUNTING REFERENCE DATE DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited interim financial information) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19: |
| 31 July Year ended 31 December 2008. 30 November 2009 (Annual Accounts) 30 April 2010 (Interims) 31 January 2011 (Annual Report) Note: The current accounting reference date is 31 December and will change on Admission to 31 July. |
| EXPECTED ADMISSION DATE: |
| 30 April 2009 |
| NAME AND ADDRESS OF NOMINATED ADVISER: |
| Zeus Capital Limited 3 Ralli Courts West Riverside Manchester M3 5FT |
| NAME AND ADDRESS OF BROKER: |
| Zeus Capital Limited 3 Ralli Courts West Riverside Manchester M3 5FT |
| OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES: |
| The Admission document will be available from the following address and will contain full details about the applicant and the admission of its securities; Zeus Capital Limited 3 Ralli Courts West Riverside Manchester M3 5FT |
| DATE OF NOTIFICATION: |
| 2 April 2009 |
| NEW/ UPDATE: |
| Update |